BioSyent Inc. (TSXV:RX)
Canada · Delayed Price · Currency is CAD 14.50
+0.45 (3.20%)
Jun 29, 2026, 11:38 AM EST
BioSyent Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 161 | 143 | 124 | 108 | 85 | 104 | |
Market Cap Growth | 23.63% | 15.53% | 14.64% | 27.83% | -18.35% | 2.40% |
Enterprise Value | 155.06 | 115.57 | 109.2 | 83.29 | 57.38 | 77.06 |
Last Close Price | 14.50 | 12.73 | 11.00 | 9.22 | 7.00 | 8.26 |
PE Ratio | 17.92 | 16.26 | 17.86 | 17.36 | 16.09 | 16.93 |
Forward PE | 14.99 | 14.98 | 14.52 | 17.23 | 13.86 | 18.77 |
PS Ratio | 3.50 | 3.33 | 3.54 | 3.43 | 3.03 | 3.62 |
PB Ratio | 3.57 | 3.46 | 3.55 | 3.11 | 2.54 | 3.29 |
P/TBV Ratio | 8.61 | 4.00 | 4.34 | 3.34 | 2.73 | 3.47 |
P/FCF Ratio | 12.96 | 16.01 | 14.40 | 21.67 | 17.28 | 22.60 |
P/OCF Ratio | 12.91 | 15.92 | 14.32 | 21.42 | 17.11 | 22.19 |
EV/Sales Ratio | 3.37 | 2.68 | 3.12 | 2.64 | 2.05 | 2.69 |
EV/EBITDA Ratio | 12.21 | 9.59 | 11.69 | 10.51 | 7.72 | 8.92 |
EV/EBIT Ratio | 13.34 | 10.33 | 12.48 | 11.15 | 8.22 | 9.42 |
EV/FCF Ratio | 12.50 | 12.91 | 12.67 | 16.67 | 11.71 | 16.79 |
Debt / Equity Ratio | 0.11 | 0.02 | 0.02 | 0.03 | 0.04 | 0.04 |
Debt / EBITDA Ratio | 0.42 | 0.07 | 0.11 | 0.15 | 0.19 | 0.18 |
Debt / FCF Ratio | 0.42 | 0.09 | 0.12 | 0.24 | 0.28 | 0.34 |
Net Debt / Equity Ratio | -0.13 | -0.67 | -0.43 | -0.72 | -0.82 | -0.84 |
Net Debt / EBITDA Ratio | -0.45 | -2.31 | -1.59 | -3.15 | -3.67 | -3.08 |
Net Debt / FCF Ratio | -0.46 | -3.11 | -1.73 | -5.00 | -5.57 | -5.81 |
Asset Turnover | 0.82 | 0.95 | 0.85 | 0.77 | 0.72 | 0.81 |
Inventory Turnover | 1.26 | 1.72 | 1.28 | 1.15 | 1.50 | 2.80 |
Quick Ratio | 1.11 | 4.60 | 3.50 | 5.37 | 5.66 | 7.59 |
Current Ratio | 1.89 | 5.51 | 4.53 | 6.48 | 6.49 | 8.24 |
Return on Equity (ROE) | 20.91% | 23.57% | 20.84% | 18.97% | 16.82% | 21.53% |
Return on Assets (ROA) | 14.26% | 18.47% | 15.70% | 13.79% | 13.21% | 17.35% |
Return on Invested Capital (ROIC) | 27.47% | 46.51% | 41.06% | 66.57% | 84.64% | 115.70% |
Return on Capital Employed (ROCE) | 25.76% | 28.63% | 24.33% | 21.12% | 20.60% | 26.63% |
Earnings Yield | 5.62% | 6.15% | 5.60% | 5.76% | 6.21% | 5.91% |
FCF Yield | 7.72% | 6.25% | 6.95% | 4.61% | 5.79% | 4.43% |
Dividend Yield | 1.57% | 1.57% | 1.63% | 1.74% | 0.56% | 0.00% |
Payout Ratio | 25.54% | 24.99% | 28.61% | 29.61% | 8.87% | 0.00% |
Buyback Yield / Dilution | 1.64% | 2.55% | 2.98% | 2.95% | 2.57% | 1.70% |
Total Shareholder Return | 3.20% | 4.12% | 4.61% | 4.69% | 3.13% | 1.70% |